A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Clinical trial NCT03173092 · TERMINATED

Trial details

NCT number: NCT03173092
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2017-11-13
Primary completion: 2026-03-30
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.